Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stapert

Showing results (101-110 of 107) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 107 results.
International Journal of Environmental Research and Public Health|December 22, 2023
Measuring the Autistic Women's Experience (AWE)Yvonne Groen, W Miro Ebert, Francien M Dittner, et al.
Bioorganic & Medicinal Chemistry|November 17, 2001
Carbon-carbon-linked (pyrazolylphenyl)oxazolidinones with antibacterial activity against multiple drug resistant gram-positive and fastidious gram-negative bacteriaC S Lee, D A Allwine, M R Barbachyn, et al.
Frontiers in Psychology|October 2, 2023
Clinical stance on response initiation in autistic adults: co-creating an integrative approach based on theory and lived experiences to act from language, via motor movement to wellbeingKirstin Greaves-Lord, Manna Alma, Benjamin de Graaff, et al.
Journal of Medicinal Chemistry|December 19, 1998
Nitrogen-carbon-linked (azolylphenyl)oxazolidinones with potent antibacterial activity against the fastidious gram-negative organisms Haemophilus influenzae and Moraxella catarrhalisM J Genin, D K Hutchinson, D A Allwine, et al.
Journal of Medicinal Chemistry|March 15, 2000
Substituent effects on the antibacterial activity of nitrogen-carbon-linked (azolylphenyl)oxazolidinones with expanded activity against the fastidious gram-negative organisms Haemophilus influenzae and Moraxella catarrhalisM J Genin, D A Allwine, D J Anderson, et al.
Journal of Medicinal Chemistry|January 10, 2003
Identification of phenylisoxazolines as novel and viable antibacterial agents active against Gram-positive pathogensMichael R Barbachyn, Gary J Cleek, Lester A Dolak, et al.
The Journal of Bone and Joint Surgery. American Volume|December 11, 2002
Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patientsShunmugam Govender, Cristina Csimma, Harry K Genant, et al.
Pageof 11

Showing results (101-110 of 107) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 107 results.
International Journal of Environmental Research and Public Health|December 22, 2023
Measuring the Autistic Women's Experience (AWE)Yvonne Groen, W Miro Ebert, Francien M Dittner, et al.
Bioorganic & Medicinal Chemistry|November 17, 2001
Carbon-carbon-linked (pyrazolylphenyl)oxazolidinones with antibacterial activity against multiple drug resistant gram-positive and fastidious gram-negative bacteriaC S Lee, D A Allwine, M R Barbachyn, et al.
Frontiers in Psychology|October 2, 2023
Clinical stance on response initiation in autistic adults: co-creating an integrative approach based on theory and lived experiences to act from language, via motor movement to wellbeingKirstin Greaves-Lord, Manna Alma, Benjamin de Graaff, et al.
Journal of Medicinal Chemistry|December 19, 1998
Nitrogen-carbon-linked (azolylphenyl)oxazolidinones with potent antibacterial activity against the fastidious gram-negative organisms Haemophilus influenzae and Moraxella catarrhalisM J Genin, D K Hutchinson, D A Allwine, et al.
Journal of Medicinal Chemistry|March 15, 2000
Substituent effects on the antibacterial activity of nitrogen-carbon-linked (azolylphenyl)oxazolidinones with expanded activity against the fastidious gram-negative organisms Haemophilus influenzae and Moraxella catarrhalisM J Genin, D A Allwine, D J Anderson, et al.
Journal of Medicinal Chemistry|January 10, 2003
Identification of phenylisoxazolines as novel and viable antibacterial agents active against Gram-positive pathogensMichael R Barbachyn, Gary J Cleek, Lester A Dolak, et al.
The Journal of Bone and Joint Surgery. American Volume|December 11, 2002
Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patientsShunmugam Govender, Cristina Csimma, Harry K Genant, et al.
Pageof 11